Pilot for State-specific Cross-Sectional Surveillance of Persons with Rare Disorders and Longitudinal Assessment of Outcomes

Post Date

December 13th 2010

Application Due Date

March 15th 2011

and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 5:00 PM Eastern Time. Note: HHS/CDC grant submission proce

Funding Opportunity Number

RFA-DD-11-004

CFDA Number(s)

93.283

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

2

Eligibility Categories

Unrestricted

Funding

• Award Range:

  $0 - $0

Grant Description

This funding opportunity announcement (FOA) has two objectives. For both Objectives 1 and 2 CDC solicits U01 cooperative agreement applications to investigate factors that influence well-being for young adults (ages 15-24 years) with rare disorders in three key domains (health, education or work, and social participation). Such investigations are needed for states’ cross-sectional surveillance efforts to document the outcomes and service use of these young adults (Objective 1). For this FOA, CDC will consider spina bifida, muscular dystrophy, and fragile x syndrome as prototypes of rare disorders. Through retrospective, longitudinal observation, these investigations may generate reasons for suboptimal outcomes among some of these young adults (Objective 2) and point the way toward changes that can improve the well-being of future young adults.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  Centers for Disease Control and Prevention (CDC)
  Procurement and Grants Office (PGO)
  Technical Information and Management Section (TIMS)
  Phone 770-488-2700

• Agency Mailing Address:

  General Email

• Agency Email Address:

  pgotim@cdc.gov

• Location:

  Centers for Disease Control and Prevention

• More Information:

  Please click on full announcement at the top of the synopsis page